Joshua Schafer's Insider Trades & SAST Disclosures
Joshua Schafer's most recent trade in Zevra Therapeutics Inc was a trade of 10,500 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joshua Schafer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 13 Feb 2025 | 10,500 | 29,486 (0%) | 0% | 7.9 | 82,527 | Common Stock |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 68,000 | 68,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 35,333 | 39,986 (0%) | 0% | - | Common Stock | |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 35,333 | 70,667 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 34,000 | 34,000 | - | - | Restricted Stock Unit | |
| Shuttle Pharmaceuticals Ho... | Joshua Schafer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 209,790 | 210,004 | - | 0 | Common Stock | |
| Shuttle Pharmaceuticals Ho... | Joshua Schafer | Director | 31 Dec 2024 | 209,790 | 210,004 | - | 0 | Common Stock | ||
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 106,000 | 106,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Purchase of securities on an exchange or from another person at price $ 5.42 per share. | 19 May 2023 | 1,000 | 3,000 (0%) | 0% | 5.4 | 5,416 | Common Stock |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Purchase of securities on an exchange or from another person at price $ 4.61 per share. | 14 Mar 2023 | 2,000 | 2,000 (0%) | 0% | 4.6 | 9,218 | Common Stock |
| Zevra Therapeutics Inc | Joshua Schafer | CCO & EVP, Bus. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges